Companies / Medicreations

Medical device company profile

Medicreations

Las Vegas manufacturer of laser, intense-pulsed-light and facial-treatment equipment for aesthetic practices.

Medical Device ManufacturerDermatology & AestheticsDermatologyMedical Aesthetics

Headquarters🇺🇸Las Vegas, Nevada, United States

FoundedNot confirmed

Commercial statusCommercially availableCommercial products are documented; authorization and availability remain product- and jurisdiction-specific.

Employees11–50 ^[30]LinkedIn company-size range · Checked 2026-10-26

Estimated revenueNot confirmed

Disclosed fundingUS$2.525 million ^[31]Debt sold · SEC filing Mar 2022

Official websitemedicreations.com ↗

Company overview

Medicreations is a Las Vegas, Nevada manufacturer of aesthetic equipment. Its website describes local device production and technical support; FDA records identify the applicant as Medicreations LLC. A reliably verified founding year and public annual revenue were not established.

The current portfolio includes MediDiode diode laser hair removal, MediYag Q-switched laser treatments, MediLight intense pulsed light, Velo CO2 laser resurfacing and the MediSpa multimodality facial platform. Commercial marketing and product-specific regulatory status are distinguished below.

Manufacturer-issued August 2026 announcements identify Ron Zakai as Chairman and CEO, Mark Sanicki as Chief Commercial Officer and Ryan Kuiper as Vice President of Sales USA. The company also advertises technical manufacturing and service roles in Las Vegas.

^{[1][2][30][31]}

Leadership

3 people

Ron ZakaiChairman & Chief Executive Officer ^[29]

Mark SanickiChief Commercial Officer ^[28]

Ryan KuiperVice President of Sales, USA ^[29]

Products & regulatory status How does MedTechIndex get this information?

Summary

Three directly matched Class II 510(k) clearances were found: K231948 for MediYag, K231950 for MediDiode and K231952 for MediLight. These are clearances, not PMA approvals or blanket approval of all products and marketing claims. ^[24][26][25]

MediDiode labeling covers hair removal/permanent reduction in Fitzpatrick I–VI, including tanned skin. MediLight labeling specifies filters, applications and Fitzpatrick I–III. MediYag indications are wavelength-specific. These distinctions take precedence over broad aesthetic marketing. ^[24][26][25]

Exact FDA linkage for the current Velo CO2 and MediSpa trade names was not established. Older MediCO references and general facility-registration or audit claims do not resolve product authorization. The current-platform FDA mapping remains unresolved. ^[1]

Published FDA searches under the company and selected product names found no relevant original PMA approvals, De Novo grants or recall events. Unrelated name matches are excluded. ^{[23][21][22][27]}

Regulatory snapshot How to read this snapshot

U.S. FDA

3
510(k) clearances: 0
De Novo grants: 0
PMA approvals: 0
Recall events

Latest recorded source review: 2026-10-27.

Commercial portfolio snapshot

Documented commercial product families.

Diode laser hair-removal system